Stay updated with breaking news from Cue Reader. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cue Health (NASDAQ:HLTH – Get Rating) and Talis Biomedical (NASDAQ:TLIS – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, analyst recommendations and institutional ownership. Valuation and Earnings This table compares Cue Health and […]
09.05.2023 - Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced that it has made a De Novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of the Cue RSV Molecular Test for at-home and point-of-care ... Seite 1
Cue Health announced today that it made a de novo submission to the FDA for clearance of its RSV molecular test.
In a letter to employees, CEO Ayub Khattak said the diagnostics company's new initiatives are "progressing well but are still early in terms of revenue generation."
The de novo submission is for a molecular diagnostic test for respiratory syncytial virus meant for home and point-of-care use.